David Risinger
Stock Analyst at Leerink Partners
(4.98)
# 60
Out of 5,070 analysts
1050
Total ratings
64.5%
Success rate
32.1%
Average return
Main Sectors:
Stocks Rated by David Risinger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $835 | $807.48 | +3.41% | 61 | Oct 20, 2026 | |
| TRAX First Tracks Biotherapeutics | Reiterated: Buy | $70 → $90 | $41.25 | +118.18% | 3 | Oct 19, 2026 | |
| JNJ Johnson & Johnson | Rated: Buy | $272 | $259.36 | +4.87% | 56 | Oct 15, 2026 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $60 | $21.83 | +174.91% | 14 | Oct 15, 2026 | |
| TENX Tenax Therapeutics | Reiterated: Buy | $4 | $1.63 | +145.40% | 11 | Oct 9, 2026 | |
| ABBV AbbVie | Reiterated: Buy | n/a | $289.08 | - | 73 | Oct 7, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $60 → $59 | $61.68 | -4.35% | 72 | Oct 7, 2026 | |
| HALO Halozyme Therapeutics | Reiterated: Buy | $110 | $124.37 | -11.55% | 39 | Oct 7, 2026 | |
| ANAB AnaptysBio | Reiterated: Buy | $81 | $45.43 | +78.30% | 35 | Sep 23, 2026 | |
| ENTX Entera Bio | Initiated Coverage: Buy | $9 | $3.02 | +198.01% | 1 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,283.66 | - | 121 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $37 | $19.82 | +86.68% | 1 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $79.09 | - | 15 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $24 | $4.05 | +492.59% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $438.94 | - | 42 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 | $514.65 | +2.01% | 44 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $73.58 | - | 58 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $32 | $34.92 | -8.36% | 47 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $30.11 | -13.65% | 90 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $66.23 | n/a | 27 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $41.40 | n/a | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.98 | n/a | 5 | Aug 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $44 | $22.88 | n/a | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $27 → $23 | $242.08 | n/a | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $39.05 | n/a | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.63 | n/a | 1 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.21 | n/a | 1 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $91 | $156.51 | n/a | 12 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.03 | n/a | 1 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $33 | $13.76 | n/a | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $176 | $213.76 | n/a | 12 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $20 → $22 | $38.80 | n/a | 15 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $148.30 | n/a | 34 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $16 | $18.65 | n/a | 24 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 → $45 | $16.17 | n/a | 19 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $49.75 | $9.01 | n/a | 32 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $22 | $44.11 | n/a | 19 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $167 → $41 | $22.70 | n/a | 8 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $167 → $174 | $80.04 | n/a | 16 | Nov 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $51 | $62.25 | n/a | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $3 | $19.84 | n/a | 4 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $343.27 | n/a | 2 | Nov 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $131.14 | n/a | 3 | Sep 21, 2012 |
Regeneron Pharmaceuticals
Oct 20, 2026
Reiterated: Hold
Price Target: $835
Current: $807.48
Upside: +3.41%
First Tracks Biotherapeutics
Oct 19, 2026
Reiterated: Buy
Price Target: $70 → $90
Current: $41.25
Upside: +118.18%
Johnson & Johnson
Oct 15, 2026
Rated: Buy
Price Target: $272
Current: $259.36
Upside: +4.87%
Tectonic Therapeutic
Oct 15, 2026
Reiterated: Buy
Price Target: $60
Current: $21.83
Upside: +174.91%
Tenax Therapeutics
Oct 9, 2026
Reiterated: Buy
Price Target: $4
Current: $1.63
Upside: +145.40%
AbbVie
Oct 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $289.08
Upside: -
Bristol-Myers Squibb Company
Oct 7, 2026
Reiterated: Hold
Price Target: $60 → $59
Current: $61.68
Upside: -4.35%
Halozyme Therapeutics
Oct 7, 2026
Reiterated: Buy
Price Target: $110
Current: $124.37
Upside: -11.55%
AnaptysBio
Sep 23, 2026
Reiterated: Buy
Price Target: $81
Current: $45.43
Upside: +78.30%
Entera Bio
Sep 18, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $3.02
Upside: +198.01%
Sep 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $1,283.66
Upside: -
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $19.82
Upside: +86.68%
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $79.09
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $30 → $24
Current: $4.05
Upside: +492.59%
Jan 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $438.94
Upside: -
Dec 29, 2025
Reiterated: Buy
Price Target: $525
Current: $514.65
Upside: +2.01%
Dec 24, 2025
Reiterated: Buy
Price Target: n/a
Current: $73.58
Upside: -
Dec 15, 2025
Reiterated: Buy
Price Target: $22 → $32
Current: $34.92
Upside: -8.36%
Dec 9, 2025
Reiterated: Hold
Price Target: $26
Current: $30.11
Upside: -13.65%
Oct 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $66.23
Upside: n/a
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $41.40
Upside: n/a
Aug 17, 2025
Reiterated: Buy
Price Target: n/a
Current: $25.98
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $60 → $44
Current: $22.88
Upside: n/a
Apr 16, 2025
Reiterated: Sell
Price Target: $27 → $23
Current: $242.08
Upside: n/a
Feb 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $39.05
Upside: n/a
Jan 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.63
Upside: n/a
May 1, 2024
Reiterated: Buy
Price Target: n/a
Current: $6.21
Upside: n/a
Apr 28, 2023
Reiterated: Hold
Price Target: $91
Current: $156.51
Upside: n/a
Mar 14, 2023
Reiterated: Buy
Price Target: n/a
Current: $12.03
Upside: n/a
Jun 11, 2021
Initiated Coverage: Hold
Price Target: $33
Current: $13.76
Upside: n/a
May 21, 2021
Reiterated: Hold
Price Target: $176
Current: $213.76
Upside: n/a
May 13, 2021
Reiterated: Sell
Price Target: $20 → $22
Current: $38.80
Upside: n/a
Apr 1, 2021
Reiterated: Buy
Price Target: $90
Current: $148.30
Upside: n/a
Mar 10, 2021
Reiterated: Hold
Price Target: $18 → $16
Current: $18.65
Upside: n/a
Mar 5, 2021
Reiterated: Hold
Price Target: $53 → $45
Current: $16.17
Upside: n/a
Feb 26, 2021
Reiterated: Hold
Price Target: $49.75
Current: $9.01
Upside: n/a
Dec 21, 2020
Reiterated: Hold
Price Target: $16 → $22
Current: $44.11
Upside: n/a
Nov 23, 2020
Reiterated: Buy
Price Target: $167 → $41
Current: $22.70
Upside: n/a
Nov 13, 2020
Reiterated: Hold
Price Target: $167 → $174
Current: $80.04
Upside: n/a
Jul 13, 2020
Initiated Coverage: Hold
Price Target: $51
Current: $62.25
Upside: n/a
Apr 2, 2020
Reiterated: Hold
Price Target: $18 → $3
Current: $19.84
Upside: n/a
Nov 16, 2015
Upgraded: Hold
Price Target: n/a
Current: $343.27
Upside: n/a
Sep 21, 2012
Reiterated: Buy
Price Target: $36
Current: $131.14
Upside: n/a